Related Experiment Videos

Novel targets of Akt, p21(Cipl/WAF1), and MDM2

Binhua P Zhou1, Mien-Chie Hung

  • 1Department of Molecular and Cellular Oncology, Breast Cancer Basic Research Program, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4095, USA.

Seminars in Oncology
|July 26, 2002
PubMed

Insights

The PI-3K/Akt pathway regulates cell growth and survival in cancer. This review explores how Akt controls cell proliferation and apoptosis by affecting its substrates, including p21(Cip1/WAF1) and MDM2.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The phosphatidylinositol-3-OH kinase (PI-3K)/Akt signaling pathway is crucial in cancer development.
  • HER2/neu amplification or overexpression, found in 30% of breast and ovarian cancers, activates this pathway.
  • Akt signaling influences cell proliferation and apoptosis.

Purpose of the Study:

  • To review the role of Akt in regulating cellular localization of its substrates.
  • To discuss how Akt controls proliferation and apoptosis.
  • To highlight the significance of new Akt substrates, p21(Cip1/WAF1) and MDM2.

Main Methods:

  • Literature review of Akt signaling and its substrates.
  • Analysis of Akt's role in substrate localization.
  • Discussion of implications for cancer biology.

Main Results:

  • Akt regulates the cellular localization of its substrates.
  • This localization control impacts cell proliferation and apoptosis.
  • p21(Cip1/WAF1) and MDM2 are identified as key Akt substrates.

Conclusions:

  • Akt's regulation of substrate localization is a key mechanism in controlling cell fate.
  • Understanding these mechanisms provides insights into tumorigenesis.
  • Targeting the PI-3K/Akt pathway and its substrates offers potential therapeutic strategies.

Related Concept Videos